AAISG 2022 Annual Meeting
Didactic lectures given by speakers in the therapeutic areas of: Genetic testing in allergy/immunology, COVID and allergy/immunology, Biologic medications and allergy/immunology, and more.
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and Allergy, Asthma and Immunology Society of Georgia (AAISG). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Target Audience
Practicing allergists and allied health care providers in the field of allergy and immunology.
Learning Objectives
At the conclusion of this activity learners should be able to:
1. Identify patients where genetic testing is indicated.
2. Choose the appropriate biologic therapy for allergic and immunologic diseases.
3. Manage the patient who previously has recovered from COVID infection.
All identified conflicts of interest have been mitigated.
The individuals listed below disclose the following financial relationships:
Bill Dolen, MD, Speaker
Consultant: Aimmune
Brian Vickery, MD, Speaker
Consultant: Aimmune, Allergenis, Aravax, DBV, FARE, Reacta, Regeneron
Researcher: Aimmune, Alladapt, DBV, FARE, Genentech, NIH-NIAID, Regeneron, Siolta
Christopher Change, MD, PhD, MBA. Speaker
Pfizer, small amount of stock
Niraj Patel, MD, Speaker
Researcher: Horizon, CSL Behring, Takeda
The following have no relevant financial relationships to disclose:
Gerald Lee, MD,Planner
Sofia Edwards-Salmon, MD, Speaker
Rachel Christina Smith, MD, Speaker
Sarah Spriet, DO, Speaker
Sarah Briggs, MD, Speaker
Safia Nawaz, MD, Speaker
Accreditation
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the American College of Allergy, Asthma & Immunology (ACAAI) and the Allergy, Asthma & Immunology Society of Georgia (AAISG). The American College of Allergy, Asthma and Immunology (ACAAI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation
The American College of Allergy, Asthma & Immunology (ACAAI) designates this live activity for a maximum of 7.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Available Credit
- 7.50 AMA PRA Category 1 Credit™
- 7.50 Attendance